Investigational Runcaciguat Reduces Albuminuria in Patients With Chronic Kidney Disease, Diabetes: Presented at ERA/EDTA

    Pers / media: Expert Comment › Popular

    Periode19-jun.-2023

    Mediabijdrages

    1

    Mediabijdrages

    • TitelInvestigational Runcaciguat Reduces Albuminuria in Patients With Chronic Kidney Disease, Diabetes: Presented at ERA/EDTA
      Mate van erkenningInternational
      Media naam/outletFirstWord Pharma
      MediatypeWeb
      Release datum19/06/2023
      URLhttps://firstwordpharma.com/story/5752709
      PersonenRon Gansevoort
    Alle bekijken 1
    Minder bekijken